US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

27.62

+0.09000.33%

Post-market: 27.53-0.0900-0.33%16:15 EDT

Volume:48

Turnover:1K

Market Cap:1.38M

PE:- -

High:27.62

Open:27.53

Low:27.62

Close:27.53

52wk High:29.89

52wk Low:24.32

Shares:50.00K

Float Shares:50.00K

Volume Ratio:0.17

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)

Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.

Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day

AbbVie Inc. Stock Underperforms Friday When Compared to Competitors

Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)

Scotiabank Remains a Buy on AbbVie (ABBV)

AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032

Estée Lauder CEOs De La Faverie, Shrivastava to Speak at Barclays Global Consumer Conference

Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live

Analysts’ Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)

Estee Lauder announces brand leadership appointments

Estée Lauder Names Justin Boxford Global President of Luxury Beauty Brands

The EstÉE Lauder Companies Announces Brand Leadership Appointments

THOMSON REUTERS

AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints

MT Newswires Live

AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study

AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS

AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals

Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26

THOMSON REUTERS

Abbvie - Etentamig Demonstrates Low Rates of Cytokine Release Syndrome and Fatal Infections

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/GLAM/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":27.6182,"timestamp":1790971200000,"preClose":27.5282,"halted":0,"volume":48,"hourTrading":{"tag":"盘后","latestPrice":27.5282,"preClose":27.6182,"latestTime":"16:15 EDT","volume":8,"amount":220.9456,"timestamp":1790972100244,"change":-0.09,"changeRate":-0.003259,"amplitude":0},"delay":0,"changeRate":0.0032693746776034545,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"Market Closed","change":0.09,"latestTime":"10-02 16:00:00 EDT","open":27.5282,"high":27.6182,"low":27.6182,"amount":1340,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"CBOE","adjPreClose":27.5282,"nav":27.51,"aum":1375500,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.5282,"preClose":27.6182,"latestTime":"16:15 EDT","volume":8,"amount":220.9456,"timestamp":1790972100244,"change":-0.09,"changeRate":-0.003259,"amplitude":0},"volumeRatio":0.17130609980336198,"impliedVol":0.0786,"impliedVolPercentile":0.0526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.17130609980336198,"shares":50000,"dividePrice":0,"high":27.6182,"amplitude":0,"preClose":27.5282,"low":27.6182,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":27.6182,"eps":0,"divideRate":0,"volume":48,"delay":0,"ttmEps":0,"open":27.5282,"prevYearClose":25.82,"prevWeekClose":28.1493,"prevMonthClose":27.766,"prevQuarterClose":27.766,"fiveDayClose":28.1493,"twentyDayClose":28.8959,"sixtyDayClose":27.8039},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665232106","title":"Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Therapeutics (SMMT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665232106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665232106?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:10","pubTimestamp":1788862214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV), Royalty Pharma (RPRX) and Summit Ther...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbvie-abbv-royalty-pharma-rprx-and-summit-therapeutics-smmt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","LU0823416689.USD","LU1551013342.USD","IE000BZT7R73.USD","LU0211327993.USD","LU1929549753.HKD","RXL","HCSG","LU1244550494.USD","LU0128525929.USD","LU2433249047.HKD","VHT","LU1003077747.HKD","LU0211328371.USD","FHLC","BK4550","LABU","LU0417517546.SGD","LU0859254822.USD","LU2125909247.SGD","PJP","XBI","LU1291159041.SGD","TRUH","FTXH","LU0553294199.USD","ABBV","LU0965509010.AUD","XLV","LU0861579265.USD","LU2237443549.SGD","LU0689626769.HKD","PPH","LU1037948897.HKD","MEDX","IHE","SMMT","JDOC","IYH","BK4137","IXJ","RPRX","IE00B3PB1722.GBP","LU2347655073.USD","LU0029874061.USD","LU1057294990.SGD","IE0004445239.USD","IE00BVYPNV92.GBP","AGNG","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665636863","title":"Plastic Surgery is Booming with Boomers. Here's How to Cash in on the Antiaging Craze.","url":"https://stock-news.laohu8.com/highlight/detail?id=2665636863","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665636863?lang=en_us&edition=fundamental","pubTime":"2026-09-05 20:30","pubTimestamp":1788611400,"startTime":"0","endTime":"0","summary":"Americans age 65 and older are suddenly the fastest-growing customers for cosmetic surgeryBoomers are the suddenly the fastest-growing customers for cosmetic surgery.Baby boomers are the wealthiest ge","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU2347655156.SGD","LU2237443978.SGD","LU0310799852.SGD","IE00BVYPNW00.USD","LU1037948897.HKD","SG9999003800.SGD","LU2129689605.HKD","LU0689626769.HKD","LU2237443549.SGD","LU2237443622.USD","BK4550","LU0708994859.HKD","LU1430594728.SGD","LU0859254822.USD","LU0472753341.HKD","IE00BLSP4452.SGD","IXJ","LU1989772840.SGD","LU1934455863.HKD","LU0289739343.SGD","LU0823416689.USD","LU0553294199.USD","LU0395794307.EUR","LU2129689514.USD","LU0985320562.USD","FTXH","LU0211327993.USD","LU0942090050.USD","LU0965509010.AUD","BK4534","LU0661504455.SGD","LU0965509101.SGD","LU1236620834.HKD","LU0098860793.USD","ESTA","LU1267930490.SGD","LU1934455277.USD","IE0002270589.USD","LU1923622614.USD","LU2129689431.USD","SG9999015945.SGD","IYH","LU0211328371.USD","SG9999015986.USD","IE00BVYPNV92.GBP","LU0511384066.AUD","LU1989771016.USD","LU0029864427.USD","LU2237443895.HKD","LU0868494708.USD","LU0912757837.SGD","LU1236620750.USD","MEDX","LU0122379950.USD","IE00B4R5TH58.HKD","BK4139","LU1244550577.SGD","BK4007","IE00BGHQF631.EUR","LU1037948541.HKD","BK4198","LU1496350502.SGD","LU1023059063.AUD","TRUH","IE000F7OJYX1.SGD","LU0820561909.HKD","LU1551013425.SGD","LU0289961442.SGD","GLAM","LU1057294990.SGD","LU2357627491.SGD","LU1929549753.HKD","IE00B3PB1722.GBP","BK4559","BK4581","LU0057025933.USD","LU0234570918.USD","LU0861579265.USD","LU0320765646.SGD","LU1093756325.SGD","LU1003077747.HKD","SG9999001440.SGD","IE00BSNM7G36.USD","LU0689472784.USD","LU1718418525.SGD","FHLC","GALDY","PJP","IE000WAW04H5.SGD","LU2133065610.SGD","IE00BLSP4239.USD","LU0949170772.SGD","LU0128525929.USD","LU0795875169.SGD","IE000MB6IJN5.SGD","LU0289739699.SGD","LU1496350171.SGD","LU2087621335.USD","LU2468319806.SGD","IE00BBT3K403.USD","IE00B2B36J28.USD","LU0726765562.USD","IE000SO60NU8.SGD","IE00BJT1NW94.SGD","LU1267930573.SGD","LU1061106388.HKD","SG9999011175.SGD","LU0882574055.USD","BK4585","LU0545039389.USD","LU2125909247.SGD","LU1162221912.USD","LU0432979614.USD","SG9999015978.USD","LU0198837287.USD","LU1551013342.USD","LU0965508806.USD","LU2089283258.USD","LU0256863902.USD","AGNG","IE00B19Z3B42.SGD","LU1244550221.USD","BK4588","LU1670627923.USD","LU2023251221.USD","LU2433249047.HKD","LU0868494617.USD","LU0310800379.SGD","LU1732799900.SGD","LU2347655073.USD","VHT","LU1074936037.SGD","LU0114720955.EUR","LU1732800096.USD","ABBV","LU2125909593.SGD","LU1093756168.USD","IE0004445239.USD","LU0456855351.SGD","LU2324357040.USD","LU1839511570.USD","LU0124676726.USD","IE00B19Z3581.USD","RXL","LU0069063385.USD","LU2089284900.SGD","LU0965509283.SGD","LU0417517546.SGD","LU0158827948.USD","LU1244550494.USD","LU0058720904.USD","IE00BDGV0183.EUR","LU1934455194.USD","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU1983299246.USD","IE00B42XCP33.USD","LU2237443382.USD","LU0738911758.USD","LU0256863811.USD","IE00BN8TJ469.HKD","LU0820561818.USD","BK4533","IE000BZT7R73.USD","LU0203347892.USD","LU1989772923.USD","LU0170899867.USD","LU0943347566.SGD","LU1585245621.USD","XLV","LU0234572021.USD","BK4566","LU0203345920.USD","LU2112291526.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","PPH","IE0000B7K699.USD","LU2089984988.USD","LU0795875086.SGD","IE0009355771.USD","LU2237443465.HKD","LU1670628061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351234","title":"Estee Lauder Cos. Cl a Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351234","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351234?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:55","pubTimestamp":1788555300,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  advanced 2.97% to $103.86 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.38% to 7,718.60 and Dow Jones Industrial Average  falling 0.51% to 53,414.25.Estee Lauder Cos. Cl A closed 14.61% below its 52-week high of $121.64, which the company achieved on February 3rd.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 1.15% to $275.23, Procter & Gamble Co.  fell 0.33% to $146.44, and Coty Inc. Cl A  remained unchanged.Trading volume  eclipsed its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","GDOC","JDOC","GLAM","LU0912757837.SGD","LU1244550494.USD","LU0098860793.USD","IE00BDGV0183.EUR","LU1244550221.USD","COTY","LU0058720904.USD","LU1732799900.SGD","UGE","LU0942090050.USD","IXJ","TRUH","IE000BZT7R73.USD","BK4018","JNJ","PJP","IYH","TRUO","RXL","VHT","BK4534","LU2471134523.USD","PG","LU0795875169.SGD","XLP","LU1221951046.USD","LU0122379950.USD","LU2896262040.SGD","LU2242652126.USD","BMED","SGXZ80539844.SGD","LU1988902786.USD","LU0640476718.USD","EL","IE00BJJMRZ35.SGD","LU0545562505.USD","LU1585245621.USD","FTXH","XLV","LU0690374615.EUR","LU0795875086.SGD","FSTA","IHE","LU1629891620.HKD","IE00B1XK9C88.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665513783","title":"AbbVie Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665513783","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665513783?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:31","pubTimestamp":1788553860,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  shed 1.44% to $256.46 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.38% to 7,718.60 and Dow Jones Industrial Average  falling 0.51% to 53,414.25.This was the stock's second consecutive day of losses.AbbVie Inc. closed 4.12% below its 52-week high of $267.47, which the company achieved on July 29th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.15% to $275.23, Pfizer Inc.  fell 1.25% to $28.45, and Amgen Inc.  fell 1.55% to $437.23.Data source: Dow Jones Market Data, FactSet. Data compiled September 4, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","LU0234572021.USD","JDOC","LU2089284900.SGD","IE000MB6IJN5.SGD","LU0912757837.SGD","LU0211328371.USD","LU1244550494.USD","LU0114720955.EUR","LU0310799852.SGD","LU0942090050.USD","LU0456855351.SGD","BK4139","IE0009355771.USD","LU2237443465.HKD","LU1670627923.USD","IE00B19Z3B42.SGD","LU0738911758.USD","BK4581","IE00B42XCP33.USD","IE00B19Z3581.USD","LU0795875169.SGD","LU1934455277.USD","IE00BSNM7G36.USD","LU0965509101.SGD","SG9999011175.SGD","BK4550","LU1037948541.HKD","IE000WAW04H5.SGD","LU0689472784.USD","LU0820561909.HKD","LU0859254822.USD","LU1989772923.USD","LU2133065610.SGD","IE00B3PB1722.GBP","LU0395794307.EUR","LU2112291526.USD","SG9999003800.SGD","BK4566","IE000F7OJYX1.SGD","LU0795875086.SGD","LU0511384066.AUD","LU1236620834.HKD","LU0545039389.USD","LU1074936037.SGD","LU1983299246.USD","LU0553294199.USD","LU1551013425.SGD","LU0868494708.USD","IE00BFTCPJ56.SGD","LU1244550221.USD","LU0417517546.SGD","IE00BLSP4239.USD","IE00BLSP4452.SGD","IE000SO60NU8.SGD","LU2023251221.USD","PJP","ABBV","IYH","LU0726765562.USD","VHT","BK4534","LU0472753341.HKD","LU1839511570.USD","LU2357627491.SGD","LU0861579265.USD","LU1244550577.SGD","LU0124676726.USD","LU0310800379.SGD","LU0868494617.USD","LU1923622614.USD","IE00BGHQF631.EUR","LU0122379950.USD","LU0170899867.USD","PPH","LU0965508806.USD","BK4533","LU2237443978.SGD","LU2129689514.USD","LU1585245621.USD","IE00BBT3K403.USD","LU0289739699.SGD","LU2125909247.SGD","XLV","LU2129689431.USD","BK4559","LU1934455863.HKD","LU1267930490.SGD","LU1023059063.AUD","IE0004445239.USD","LU0820561818.USD","SG9999001440.SGD","MEDX","LU0708994859.HKD","FHLC","LU0965509283.SGD","GLAM","LU0158827948.USD","IE0002270589.USD","LU2237443895.HKD","LU1732799900.SGD","LU0256863811.USD","LU1061106388.HKD","LU0943347566.SGD","LU0882574055.USD","IE00BJT1NW94.SGD","SG9999015952.SGD","AGNG","IE000BZT7R73.USD","LU2468319806.SGD","LU0029864427.USD","LU1496350171.SGD","RXL","LU0203347892.USD","LU1057294990.SGD","LU1551013342.USD","LU2129689605.HKD","LU2089283258.USD","LU1267930573.SGD","LU2237443622.USD","LU0661504455.SGD","IE00B4R5TH58.HKD","BK4585","LU0256863902.USD","LU2087621335.USD","LU0198837287.USD","BK4588","LU0289739343.SGD","IE0002141913.USD","LU1236620750.USD","LU1989771016.USD","LU0985320562.USD","LU1162221912.USD","SG9999015945.SGD","LU0320765646.SGD","LU1732800096.USD","IE0000B7K699.USD","LU1093756168.USD","LU0057025933.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU0234570918.USD","LU0098860793.USD","IE00BDGV0183.EUR","LU0058720904.USD","LU1718418525.SGD","IXJ","LU1291159041.SGD","TRUH","IE00BVYPNW00.USD","LU0823416689.USD","LU1989772840.SGD","LU2347655156.SGD","LU0128525929.USD","LU1934455194.USD","LU2125909593.SGD","LU1496350502.SGD","SG9999015986.USD","LU0069063385.USD","LU2433249047.HKD","SG9999015978.USD","LU0289961442.SGD","LU1670628061.USD","LU1003077747.HKD","LU0689626769.HKD","LU0949170772.SGD","LU1093756325.SGD","LU0203345920.USD","IE00BVYPNV92.GBP","IE00BJJMRZ35.SGD","LU0965509010.AUD","LU1037948897.HKD","FTXH","LU2347655073.USD","LU2237443382.USD","LU2089984988.USD","IE00BN8TJ469.HKD","LU1929549753.HKD","LU0211327993.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664162337","title":"Analysts Are Bullish on Top Healthcare Stocks: Annovis Bio (ANVS), AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664162337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664162337?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:40","pubTimestamp":1788529214,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Annovis Bio (ANVS), AbbVie (ABBV) and Glaukos (GKOS)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-annovis-bio-anvs-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-annovis-bio-anvs-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABBV","GKOS","HCSG","BK4533","ANVS","LU0128525929.USD","LU0122379950.USD","FHLC","LABU","LU2125909593.SGD","XLV","LU0029864427.USD","XBI","MEDX","LU0211327993.USD","IE00BN8TJ469.HKD","IYH","VHT","AGNG","IE0002270589.USD","JDOC","RXL","LU1732799900.SGD","IE00BJJMRZ35.SGD","TRUH","IE00BBT3K403.USD","LU1057294990.SGD","BK4585","LU0708994859.HKD","GLAM","LU0211328371.USD","LU1074936037.SGD","LU1934455194.USD","IXJ","LU2237443622.USD","LU2347655156.SGD","LU1923622614.USD","IE00BSNM7G36.USD","PPH","LU1718418525.SGD","LU1430594728.SGD","IE00BLSP4452.SGD","SG9999015986.USD","LU0689626769.HKD","SG9999015945.SGD","FTXH","LU0128526141.USD","LU0965509010.AUD","PJP","LU0472753341.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339449","title":"Scotiabank Remains a Buy on AbbVie (ABBV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339449","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339449?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:35","pubTimestamp":1788521731,"startTime":"0","endTime":"0","summary":"In a report released today, Louise Chen from Scotiabank maintained a Buy rating on AbbVie, with a price target of $280.00. Chen covers the Healthca...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-remains-a-buy-on-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-remains-a-buy-on-abbvie-abbv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VHT","LU0689626769.HKD","LU1923622614.USD","LU1983299246.USD","LU0949170772.SGD","LU2468319806.SGD","LU0553294199.USD","PJP","XLV","LU2237443622.USD","FHLC","LU2023251221.USD","LU0128525929.USD","LU1291159041.SGD","GLAM","LU0859254822.USD","LU2237443978.SGD","LU2433249047.HKD","LU1057294990.SGD","LU0689472784.USD","LU0965508806.USD","LU1267930573.SGD","LU1267930490.SGD","MEDX","LU0029864427.USD","PPH","LU2129689605.HKD","LU0057025933.USD","LU1244550221.USD","SG9999011175.SGD","IE000MB6IJN5.SGD","LU1839511570.USD","LU1236620834.HKD","IE00BLSP4239.USD","ABBV","JDOC","LU0820561818.USD","RXL","TRUH","IXJ","LU2347655073.USD","LU0472753341.HKD","IYH","LU0738911758.USD","LU0114720955.EUR","SG9999015978.USD","LU1162221912.USD","FTXH","AGNG","LU1670627923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127014248","title":"AbbVie Closes $10.9B Takeover of Apogee, Its Largest Deal Since 2019, With Earnings Lift Expected From 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1127014248","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127014248?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:44","pubTimestamp":1788486257,"startTime":"0","endTime":"0","summary":"AbbVie (NYSE: ABBV) announced on Thursday that it has finalized its $10.9 billion acquisition of inflammation drug developer Apogee Therapeutics (NASDAQ: APGE). This transaction marks the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B42XCP33.USD","LU0211328371.USD","LU2237443622.USD","LU2089984988.USD","LU0859254822.USD","LU2129689605.HKD","LU0726765562.USD","LU1037948541.HKD","LU0124676726.USD","IE00B19Z3581.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","BK4534","LU1236620750.USD","LU1244550577.SGD","IE000BZT7R73.USD","LU0058720904.USD","LU1291159041.SGD","IXJ","PPH","LU0661504455.SGD","XLV","LU0289961442.SGD","BK4581","IE00BDGV0183.EUR","LU0395794307.EUR","LU1934455194.USD","LU0511384066.AUD","LU1037948897.HKD","SG9999015986.USD","LU2133065610.SGD","LU0456855351.SGD","LU0820561909.HKD","SG9999015978.USD","XMMO","LU1983299246.USD","LU0965508806.USD","LU0689472784.USD","LU0553294199.USD","IE000WAW04H5.SGD","LU0128525929.USD","FTXH","LU1732800096.USD","SG9999003800.SGD","LU0320765646.SGD","LU0256863811.USD","LU0965509283.SGD","LU2125909247.SGD","IE0000B7K699.USD","LU0114720955.EUR","LU0795875086.SGD","SG9999015952.SGD","LU0882574055.USD","BK4139","MYLD","SG9999011175.SGD","LU0985320562.USD","LU2237443382.USD","LU0861579265.USD","LU1585245621.USD","LU0417517546.SGD","BK4588","LU0943347566.SGD","LU1551013425.SGD","IE0002141913.USD","LU0211327993.USD","LU0942090050.USD","LU1061106388.HKD","LU2237443549.SGD","LU0738911758.USD","LU2347655073.USD","PJP","LU1267930490.SGD","BK4550","LU0029864427.USD","LU1496350502.SGD","LU2112291526.USD","IE0009355771.USD","BK4585","LU2237443895.HKD","LU1244550221.USD","LU0170899867.USD","LU2023251221.USD","LU0545039389.USD","IE00B3PB1722.GBP","LU1923622614.USD","LU2347655156.SGD","IE00BLSP4239.USD","LU0868494617.USD","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0234570918.USD","LU1093756168.USD","IE00BLSP4452.SGD","LU2089284900.SGD","LU0256863902.USD","LU0098860793.USD","LU1496350171.SGD","LU0472753341.HKD","LU1074936037.SGD","LU1839511570.USD","LU0122379950.USD","BK4559","LU2125909593.SGD","AGNG","LU1551013342.USD","LU1732799900.SGD","IE0004445239.USD","LU1023059063.AUD","LU0795875169.SGD","GLAM","LU1244550494.USD","LU2237443465.HKD","IE00BN8TJ469.HKD","JDOC","IE000SO60NU8.SGD","LU2357627491.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0432979614.USD","IE00BBT3K403.USD","RXL","LU0965509010.AUD","FHLC","LU0310799852.SGD","IE00BGHQF631.EUR","IE00BVYPNW00.USD","LU0234572021.USD","LU1934455277.USD","LU2129689431.USD","LU2237443978.SGD","LU0708994859.HKD","LU0053671581.USD","LU1003077747.HKD","LU0912757837.SGD","VHT","SBIO","LU1989772840.SGD","IE00B19Z3B42.SGD","IE000MB6IJN5.SGD","LU1934455863.HKD","LU0203347892.USD","LU2129689514.USD","APGE","IE00B2B36J28.USD","KCE","LU0868494708.USD","MEDX","LU0203345920.USD","CALF","LU1989772923.USD","LU0198837287.USD","LU1670628061.USD","LU1162221912.USD","LU0289739699.SGD","ABBV","LU0069063385.USD","LU2433249047.HKD","BK4566","LU0158827948.USD","IE0002270589.USD","LU0949170772.SGD","LU1057294990.SGD","LU1267930573.SGD","LU1670627923.USD","TRUH","LU0820561818.USD","IE000F7OJYX1.SGD","LU0823416689.USD","LU1430594728.SGD","LU0289739343.SGD","LU2089283258.USD","SG9999015945.SGD","IYH","IE00BSNM7G36.USD","BK4533","IE00BVYPNV92.GBP","LU1929549753.HKD","LU0965509101.SGD","LU1989771016.USD","LU0057025933.USD","SG9999001440.SGD","LU0689626769.HKD","LU1236620834.HKD","LU2087621335.USD","LU0310800379.SGD","LU1718418525.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664780801","title":"Estée Lauder CEOs De La Faverie, Shrivastava to Speak at Barclays Global Consumer Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664780801","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664780801?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:35","pubTimestamp":1788467719,"startTime":"0","endTime":"0","summary":"Estée Lauder CEOs de La Faverie, Shrivastava to speak at Barclays Global Consumer ConferenceEstée Lauder will participate in the Barclays Annual Global Consumer Conference in Boston on Sept. 9, 2026.C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL7pV1jp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2404859741.USD","LU1988902786.USD","LU2264538146.SGD","BK4585","LU2552382215.SGD","LU2552382058.USD","LU0690374961.EUR","LU1064131342.USD","BK4533","GLAM","EL","BK4183","LU2404859667.USD","BK4504","LU0690374615.EUR","LU2552382132.HKD","BK4548","BK4558"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980123","title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980123","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664980123?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:32","pubTimestamp":1788467558,"startTime":"0","endTime":"0","summary":"Hims & Hers Chief Legal Officer Soleil Boughton disposes of 3,458 common shares for $97,961.14Soleil Boughton, Chief Legal Officer at Hims & Hers Health, sold 3,458 Class A common shares on Sept. 2.Sa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL24pSk7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Chief Legal Officer Soleil Boughton Disposes of 3,458 Common Shares for $97,961.14","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","HIMC","GLAM","HIMZ","HIYY","BK4196","HIMS","HIMY","HMYY","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080500","title":"Sector Update: Healthcare Stocks Higher Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080500?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:49","pubTimestamp":1788457760,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Hutchmed  shares jumped 17% after the company said its unit licensed rights to GSK  to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.3%.Ultragenyx Pharmaceutical  shares fell 45% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1244550577.SGD","BK4534","LU1496350171.SGD","TRUH","LU0553294199.USD","JDOC","LU0029864427.USD","IE00B4R5TH58.HKD","VHT","HCM","GSK.UK","LU0289961442.SGD","RXL","ABBV","IYH","MEDX","IXJ","LU0203345920.USD","LU0432979614.USD","GSK","AGNG","LU0124676726.USD","LU0256863811.USD","LU1236620750.USD","LU1989772923.USD","APGE","PPH","HCSG","FHLC","GSKH","GLAM","LABU","LU2125909593.SGD","SBIO","LU1718418525.SGD","PJP","IE00BGHQF631.EUR","IBB","LU0820561909.HKD","BK4137","LU0708994859.HKD","RARE","IE0004445239.USD","LU2237443382.USD","LU0114720955.EUR","XLV","XBI","LU0128525929.USD","FTXH","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803903","title":"Analysts’ Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803903","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803903?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:50","pubTimestamp":1788450609,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Align Tech (ALGN) and Eledon Pharmaceuticals (ELDN) ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-align-tech-algn-eledon-pharmaceuticals-eldn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-align-tech-algn-eledon-pharmaceuticals-eldn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4585","XBI","BK4139","LU0029874061.USD","HCSG","BK4588","BK4581","LU2106854487.HKD","LU0128526141.USD","LU1917777945.USD","LABU","LU1974910355.USD","BK4504","ALGN","GLAM","XLV","LU2023250843.SGD","BK4198","BK4534","LU2023250504.SGD","ELDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664808927","title":"Estee Lauder announces brand leadership appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2664808927","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664808927?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:40","pubTimestamp":1788446411,"startTime":"0","endTime":"0","summary":"Estee Lauder (EL) announced several brand leadership appointments following the upcoming retirement of Sandra Main, Global Brand President, La Mer ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/estee-lauder-announces-brand-leadership-appointments-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/estee-lauder-announces-brand-leadership-appointments-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4183","LU2552382215.SGD","LU0690374961.EUR","LU1988902786.USD","LU0690374615.EUR","LU1064131342.USD","EL","BK4585","GLAM","LU2552382132.HKD","BK4558","BK4504","BK4588","LU2404859667.USD","BK4548","LU2264538146.SGD","LU2552382058.USD","LU2404859741.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664687000","title":"Estée Lauder Names Justin Boxford Global President of Luxury Beauty Brands","url":"https://stock-news.laohu8.com/highlight/detail?id=2664687000","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664687000?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:37","pubTimestamp":1788446260,"startTime":"0","endTime":"0","summary":"Estée Lauder names Justin Boxford global president of luxury beauty brandsEstée Lauder created a Global President, Luxury Beauty Brands role, naming Justin Boxford to oversee La Mer alongside other lu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL2PfpdR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","GLAM","BK4558","BK4585","LU2404859667.USD","LU2552382215.SGD","BK4588","BK4533","BK4504","BK4548","LU0690374961.EUR","LU0690374615.EUR","EL","LU2404859741.USD","LU2264538146.SGD","LU1988902786.USD","LU2552382058.USD","LU2552382132.HKD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870020","title":"The EstÉE Lauder Companies Announces Brand Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870020","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870020?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:37","pubTimestamp":1788446220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA8VM31T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","EL","LU2264538146.SGD","BK4558","BK4504","LU1064131342.USD","BK4585","LU2404859667.USD","BK4548","LU1988902786.USD","BK4588","LU0690374615.EUR","BK4533","GLAM","LU0690374961.EUR","LU2552382058.USD","LU2404859741.USD","LU2552382215.SGD","LU2552382132.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870565","title":"AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870565","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870565?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:07","pubTimestamp":1788444473,"startTime":"0","endTime":"0","summary":"AbbVie's (ABBV) phase 3 study of etentamig in patients with triple-class exposed relapsed/refractory multiple myeloma met its dual primary endpoints of objective response rate and progression-free sur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089984988.USD","LU2129689514.USD","LU0256863902.USD","SG9999015952.SGD","AGNG","LU1732799900.SGD","MEDX","LU2468319806.SGD","LU1670628061.USD","IE0004445239.USD","IXJ","LU0289739699.SGD","ABBV","GLAM","LU2237443465.HKD","JDOC","LU2237443549.SGD","IE000SO60NU8.SGD","LU2433249047.HKD","LU0661504455.SGD","LU1057294990.SGD","LU2357627491.SGD","PPH","PJP","LU1267930490.SGD","TRUH","XLV","BK4581","IE0009355771.USD","SG9999015986.USD","LU0289739343.SGD","IYH","LU0456855351.SGD","IE00BBT3K403.USD","LU0820561909.HKD","RXL","LU0965509010.AUD","FHLC","IE00BVYPNW00.USD","IE00BGHQF631.EUR","LU1923622614.USD","SG9999001440.SGD","IE000WAW04H5.SGD","IE00BJT1NW94.SGD","FTXH","VHT","SG9999003800.SGD","LU0320765646.SGD","LU0965509283.SGD","LU1718418525.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587722","title":"AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587722","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587722?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:42","pubTimestamp":1788442920,"startTime":"0","endTime":"0","summary":"AbbVie said a drug to treat blood cancer met its dual primary endpoints in a phase 3 study.The company said etentamig demonstrated a significantly higher objective response rate and improvements in pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","IE00BBT3K403.USD","GLAM","IE00B19Z3B42.SGD","LU1003077747.HKD","LU0256863902.USD","FHLC","BK4585","IYH","LU0098860793.USD","LU0861579265.USD","LU0124676726.USD","LU1244550221.USD","LU0289961442.SGD","FTXH","LU0170899867.USD","LU1732799900.SGD","LU1291159041.SGD","LU0472753341.HKD","LU0203347892.USD","IE000F7OJYX1.SGD","LU0868494708.USD","IE0000B7K699.USD","MEDX","IE00B42XCP33.USD","IE00BVYPNV92.GBP","XLV","IE00BLSP4452.SGD","ABBV","JDOC","IXJ","TRUH","IE000BZT7R73.USD","LU0823416689.USD","LU0868494617.USD","LU1093756325.SGD","PPH","LU2129689431.USD","LU0211328371.USD","PJP","RXL","VHT","SG9999001440.SGD","LU2237443978.SGD","AGNG","IE00BDGV0183.EUR","LU0859254822.USD","LU2089283258.USD","LU2112291526.USD","LU1551013342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587723","title":"AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587723","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587723?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:25","pubTimestamp":1788441947,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced positive topline results from the Phase 3 Cervino study evaluating etentamig, an investigational BCMA x CD3 bispecific T-ce...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-announces-phase-3-cervino-study-met-dual-primary-endpoints-of-orr-pfs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-announces-phase-3-cervino-study-met-dual-primary-endpoints-of-orr-pfs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","IE00BJJMRZ35.SGD","LU1057294990.SGD","MEDX","LU2089284900.SGD","XLV","RXL","SG9999011175.SGD","BK4559","LU0820561909.HKD","LU1585245621.USD","TRUH","JDOC","LU0124676726.USD","AGNG","LU0472753341.HKD","LU0057025933.USD","LU0795875169.SGD","LU0912757837.SGD","LU1929549753.HKD","IE00BLSP4239.USD","LU1496350171.SGD","IE000WAW04H5.SGD","LU0203347892.USD","LU0965509283.SGD","VHT","PJP","IE0004445239.USD","LU1093756325.SGD","ORR","LU0868494617.USD","LU0417517546.SGD","LU0320765646.SGD","LU2129689431.USD","BK4550","FTXH","LU0942090050.USD","FHLC","GLAM","BK4585","LU0256863811.USD","PPH","IE000F7OJYX1.SGD","LU1244550494.USD","ABBV","IXJ","LU1989772840.SGD","LU2357627491.SGD","LU2237443465.HKD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877895","title":"AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877895","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877895?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:18","pubTimestamp":1788441527,"startTime":"0","endTime":"0","summary":"AbbVie's blood cancer drug meets late-stage trial goalsSept 3 (Reuters)-AbbVieABBV.Nsaid on Thursday its drug for a type of blood cancer has met the main goals of a late-stage trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","LU0395794307.EUR","LU0211328371.USD","SG9999015952.SGD","LU1934455277.USD","ABBV","PPH","RXL","SG9999001440.SGD","IE00BLSP4239.USD","LU0128525929.USD","LU2112291526.USD","JDOC","LU0289961442.SGD","LU0942090050.USD","LU0114720955.EUR","IE0004445239.USD","LU1934455863.HKD","LU0203345920.USD","LU0820561909.HKD","XLV","FTXH","LU1989772923.USD","IE00BN8TJ469.HKD","IE00BVYPNW00.USD","LU0256863902.USD","IE0009355771.USD","LU0820561818.USD","PJP","LU0726765562.USD","GLAM","LU1585245621.USD","LU0985320562.USD","IE00B3PB1722.GBP","VHT","LU0472753341.HKD","AGNG","TRUH","IYH","IE00BBT3K403.USD","LU1496350171.SGD","BK4585","LU2357627491.SGD","LU0098860793.USD","MEDX","FHLC","LU2089283258.USD","IXJ","LU0057025933.USD","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887207","title":"Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887207?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PPH","IE00B4R5TH58.HKD","LU1718418525.SGD","VHT","LU1057294990.SGD","LU2347655073.USD","GLAM","LU0511384066.AUD","LU1670628061.USD","FTXH","LU1093756325.SGD","MEDX","LU0122379950.USD","LU0114720955.EUR","LU2125909593.SGD","LU1267930573.SGD","LU1291159041.SGD","LU1023059063.AUD","LU1496350171.SGD","LU1244550221.USD","LU0859254822.USD","LU2087621335.USD","FHLC","ABBV","LU1244550577.SGD","LU0965509010.AUD","LU1551013425.SGD","PJP","IXJ","XLV","LU0098860793.USD","LU1983299246.USD","LU1236620834.HKD","LU0553294199.USD","TRUH","BK4533","JDOC","IYH","LU1585245621.USD","AGNG","IE00BBT3K403.USD","LU2133065610.SGD","LU0234572021.USD","LU2237443549.SGD","LU1839511570.USD","LU0820561909.HKD","IE00BN8TJ469.HKD","RXL","LU2089984988.USD","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872073","title":"Abbvie - Etentamig Demonstrates Low Rates of Cytokine Release Syndrome and Fatal Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872073?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","AGNG","LU1244550577.SGD","IE000WAW04H5.SGD","IE00BBT3K403.USD","MEDX","FTXH","LU1934455194.USD","LU0511384066.AUD","TRUH","VHT","ABBV","LU0861579265.USD","LU1430594728.SGD","LU1244550494.USD","LU0859254822.USD","FHLC","LU1732800096.USD","LU0795875169.SGD","LU1989771016.USD","RXL","LU0128525929.USD","SG9999011175.SGD","IXJ","XLV","LU0170899867.USD","IE00B2B36J28.USD","GLAM","IE00B3PB1722.GBP","JDOC","LU2237443465.HKD","IYH","LU2237443382.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0942090050.USD","PJP","SG9999015945.SGD","LU1839511570.USD","LU2089283258.USD","LU0545039389.USD","SG9999001440.SGD","PPH","SG9999003800.SGD","LU1093756325.SGD","LU0943347566.SGD","LU1934455863.HKD","LU2125909593.SGD","LU0456855351.SGD","LU0289961442.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}